tiprankstipranks
Editas Medicine Inc (EDIT)
NASDAQ:EDIT
US Market

Editas Medicine (EDIT) Financial Statements

Compare
3,428 Followers

Editas Medicine Financial Overview

Editas Medicine's market cap is currently $107.87M. The company's EPS TTM is $-2.882; its P/E ratio is ―; Editas Medicine is scheduled to report earnings on February 26, 2025, and the estimated EPS forecast is $-0.56. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 32.31M$ 78.12M$ 19.71M$ 25.54M$ 90.73M
Gross Profit$ 32.31M$ -99.53M$ 13.38M$ 20.49M$ -67.26M
Operating Income$ -251.15M$ -169.18M$ -225.95M$ -193.15M$ -134.84M
EBITDA$ -233.11M$ -163.12M$ -219.61M$ -188.09M$ -130.88M
Net Income$ -237.09M$ -153.22M$ -204.35M$ -185.11M$ -109.41M
Balance Sheet
Cash & Short-Term Investments$ 269.91M$ 323.11M$ 437.37M$ 619.91M$ 511.77M
Total Assets$ 341.59M$ 499.15M$ 514.32M$ 677.48M$ 572.60M
Total Debt$ 35.03M$ 36.54M$ 43.95M$ 26.38M$ 26.14M
Net Debt$ -96.51M$ -87.12M$ -97.58M$ -177.14M$ -113.55M
Total Liabilities$ 207.31M$ 150.06M$ 153.64M$ 123.84M$ 179.02M
Stockholders' Equity$ 134.27M$ 349.10M$ 360.68M$ 553.64M$ 393.59M
Cash Flow
Free Cash Flow$ -219.11M$ -136.90M$ -181.47M$ -171.78M$ -187.00M
Operating Cash Flow$ -210.28M$ -132.18M$ -177.35M$ -163.80M$ -179.84M
Investing Cash Flow$ 162.15M$ -3.73M$ 114.07M$ -54.47M$ -140.52M
Financing Cash Flow$ 56.03M$ 118.04M$ 1.28M$ 282.11M$ 224.12M
Currency in USD

Editas Medicine Earnings and Revenue History

Editas Medicine Debt to Assets

Editas Medicine Cash Flow

Editas Medicine Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis